2025-06283Notice

Merck Expands NJ Pharma Lab with Foreign-Trade Zone Perks

Published Date: 4/14/2025

Notice

Summary

Merck, Sharp & Dohme LLC wants to expand their Rahway, New Jersey facility to make new pharmaceutical products for diseases like cancer and infections using special foreign materials. This change lets them save on import duties and speed up research. Public comments are open until May 27, 2025, so folks can share their thoughts before the plan moves forward.

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
4/14/2025

Department and Agencies

Department
Independent Agency
Agency
Commerce Department
Foreign-Trade Zones Board
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register